{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:16:05Z","timestamp":1791274565245,"version":"4.1.0"},"reference-count":105,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T00:00:00Z","timestamp":1274227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:p>Current drugs used in the treatment of Parkinson's disease (PD), for example, L\u2010DOPA and dopamine agonists, are very effective at reversing the motor symptoms of the disease. However, they do little to combat the underlying degeneration of dopaminergic neurones in the substantia nigra pars compacta (SNc) and their long\u2010term use is associated with the appearance of adverse effects such as L\u2010DOPA\u2010induced dyskinesia. Much emphasis has therefore been placed on finding alternative non\u2010dopaminergic drugs that may circumvent some or all of these problems. Group III metabotropic glutamate (mGlu) receptors were first identified in the basal ganglia a decade ago. One or more of these receptors (mGlu4, mGlu7 or mGlu8) is found on pre\u2010synaptic terminals of basal ganglia pathways whose overactivity is implicated not only in the generation of motor symptoms in PD, but also in driving the progressive SNc degeneration. The finding that drugs which activate group III mGlu receptors can inhibit transmission across these overactive synapses has lead to the proposal that group III mGlu receptors are promising targets for drug discovery in PD. This paper provides a comprehensive review of the role and target potential of group III mGlu receptors in the basal ganglia. Overwhelming evidence obtained from <jats:italic>in vitro<\/jats:italic> studies and animal models of PD supports group III mGlu receptors as potentially important drug targets for providing both symptom relief and neuroprotection in PD.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.00882.x","type":"journal-article","created":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T10:50:04Z","timestamp":1274352604000},"page":"271-287","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease"],"prefix":"10.1111","volume":"161","author":[{"given":"Susan","family":"Duty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,23]]},"reference":[{"key":"e_1_2_13_2_1","first-page":"S1","article-title":"Guide to Receptors and Channels (GRAC), 3rd edition (2008 revision)","volume":"153","author":"Alexander SPH","year":"2008","journal-title":"Br J Pharmacol"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932060-00004"},{"key":"e_1_2_13_4_1","first-page":"2106","article-title":"Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins","volume":"17","author":"Aronica E","year":"2003","journal-title":"Eur J Neurol"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00820.x"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2008.11.007"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1595-06.2006"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70291-6"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-13-05403.2002"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(09)70469-9"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-131789"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00033-4"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02740748"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(99)00067-2"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb11322.x"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(82)90019-3"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0750889.x"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70068-7"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.37.1.205"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1763"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(01)00591-7"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.06036.x"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703105"},{"key":"e_1_2_13_25_1","volume-title":"World Population Ageing 2009","author":"Department of Economic and Social Affairs","year":"2009"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.62.1.10"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00229003"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301531"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9005065"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21475"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.04.018"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/114.5.2283"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.08.020"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2003.07.013"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.3.378"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-1931(00)00021-5"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00929.x"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.65.5.1103"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1999.82.2.925"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(02)00038-X"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2471"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0118-06.2006"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.166629"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.08.010"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902600309"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-006-0316-z"},{"key":"e_1_2_13_47_1","first-page":"611","article-title":"The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)\u20101\u2010aminocyclopentane\u20101,3,4\u2010tricarboxylic acid on the parkinsonian like akinesia and striatal proenkephalin and prodynorphin expression in rats","volume":"145","author":"Konieczny J","year":"2007","journal-title":"Neuropharmacology"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00047-9"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19991213)415:2<266::AID-CNE9>3.0.CO;2-7"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810083391506"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0299-07.2007"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.06.038"},{"key":"e_1_2_13_53_1","first-page":"303","article-title":"Surgery for Parkinson's disease, the five W's: why, who, what, where, and when","volume":"91","author":"Lozano AM","year":"2003","journal-title":"Adv Neurol"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.10.030"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705566"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(03)00271-5"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.04.006"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1835724100"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91146-1"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1999.0732469.x"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00415-9"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(02)00090-4"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508063102"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.3.314"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(02)00842-0"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.049551"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.08.087"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-1931(00)00028-8"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22062"},{"key":"e_1_2_13_70_1","first-page":"295","article-title":"Potential antipsychotic and extrapyramidal effects of (R,S)\u20103,4\u2010dicarboxyphenylglycine [(R,S)\u20103,4\u2010DCPG], a mixed AMPA antagonist\/mGluR8 agonist","volume":"56","author":"Ossowska K","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2003.09.006"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.06.033"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508628200"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1632"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.02.011"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1996.tb01603.x"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(96)00177-3"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M503483200"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440726"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2005.11.023"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(00)00098-X"},{"key":"e_1_2_13_82_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.150425"},{"key":"e_1_2_13_83_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-19-05979.1996"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(08)70021-X"},{"key":"e_1_2_13_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902940213"},{"key":"e_1_2_13_86_1","first-page":"353","article-title":"Microcircuitry of the direct and indirect pathways of the basal ganglia","volume":"86","author":"Smith Y","year":"1998","journal-title":"Neuroscience"},{"key":"e_1_2_13_87_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-06-02150.2003"},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.14-05-03005.1994"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00169-6"},{"key":"e_1_2_13_90_1","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1523\/JNEUROSCI.12-06-02043.1992","article-title":"L\u2010AP4 inhibits calcium currents and synaptic transmission via a G\u2010protein\u2010coupled glutamate receptor","volume":"12","author":"Trombley PQ","year":"1992","journal-title":"J Neurosci"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-18-07218.2003"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.080481"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2005.04362.x"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.108159"},{"key":"e_1_2_13_95_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1999.0730344.x"},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707167"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701662"},{"key":"e_1_2_13_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.11.104"},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2001.85.5.1960"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.033266"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.07.060"},{"key":"e_1_2_13_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02937.x"},{"key":"e_1_2_13_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(96)00149-2"},{"key":"e_1_2_13_104_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200825080-00004"},{"key":"e_1_2_13_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.10.042"},{"key":"e_1_2_13_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20897"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.00882.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00882.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T22:06:06Z","timestamp":1697407566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.00882.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,23]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1476-5381.2010.00882.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00882.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,23]]},"assertion":[{"value":"2010-08-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}